Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 3/20 | 0.53 |
| ▸ | HTR3A | P46098 | 3/20 | 0.53 |
| ▸ | AR | P10275 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.40 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9488050 | 0.86 | HTR1A (0.48) | HTR1AHTR3AARIDO1ACHE | |
| SCHEMBL9487673 | 0.84 | HTR1A (0.45) | HTR1AHTR3AIDO1ACHEMAPT | |
| SCHEMBL14306498 | 0.83 | AR (0.44) | HTR1AHTR3AARIDO1ACHE | |
| SCHEMBL9488631 | 0.83 | AR (0.46) | HTR1AHTR3AARIDO1ACHE | |
| SCHEMBL25704500 | 0.81 | SLC6A2 (0.58) | ARIDO1L3MBTL1KDM4EGRM5 | |
| SCHEMBL20222309 | 0.81 | HTR1A (0.50) | HTR1AHTR3AIDO1ACHEMAPT | |
| SCHEMBL20845202 | 0.81 | AR (0.43) | HTR1AHTR3AARIDO1L3MBTL1 | |
| SCHEMBL2876479 | 0.81 | L3MBTL1 (0.50) | HTR1AHTR3AARACHEMAPT | |
| SCHEMBL29580858 | 0.81 | L3MBTL1 (0.50) | HTR1AHTR3AARACHEMAPT | |
| SCHEMBL575896 | 0.80 | ACHE (0.58) | HTR1AHTR3AIDO1ACHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| US-9650456-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | TOYO GOSEI CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| EP-2825574-B1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORP (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-20150031845-A1 | Process For Producing Polydienes | BRIDGESTONE CORPORATION (JP) | 2015-01-29 | — | — | US | disclosed |
| EP-2825574-A1 | PROCESS FOR PRODUCING POLYDIENES | Bridgestone Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| WO-2013138270-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTSONE CORPORATION (JP) | 2013-09-19 | — | — | WO | disclosed |
| US-7709548-B2 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | SAN-APRO LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| EP-1350789-B1 | PROCESS FOR PRODUCING SULFONIUM SALT | SAN APRO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | DATE MASASHI | 2008-05-08 | — | — | US | disclosed |
| EP-1640363-B1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | SAN APRO LTD (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | SAN-APRO LIMITED (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7060858-B2 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2006-06-13 | — | — | US | disclosed |
| EP-1640363-A1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | San-Apro Limited (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1350789-A1 | PROCESS FOR PRODUCING SULFONIUM SALT | San-Apro Limited (JP) | 2003-10-08 | — | — | EP | disclosed |
| US-5250657-A | Process for preparing polyarylene thioether | SEISAN KAIHATSU KAGAKU KENKYUSHO (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0440106-A2 | Process for preparing polyarylene thioethers | SEISAN KAIHATSU KAGAKU KENKYUSHO (JP) | 1991-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | RPS6, SPIN4, SRM | HTR1A 4183/4885HTR3A 4786/4885AR 3511/4885 |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | MLX, STS, SULT1A1 | HTR1A 1713/4885HTR3A 3119/4885AR 1457/4885 |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | ARSA, SCO2, DOHH | HTR1A 3175/4885HTR3A 2650/4885AR 12/4885 |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SPIN4, RPS6, SRM | HTR1A 4406/4885HTR3A 4796/4885AR 3539/4885 |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | STS, SULT1A1, ARSA | HTR1A 3074/4885HTR3A 2966/4885AR 2653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.